Core Molding Tech (CMT) shares fell after missing Q3 2025 earnings and revenue estimates. The company also lowered its full-year sales guidance, citing a challenging market.
Core Molding Technologies beats Q2 revenue and EPS estimates but shares dip slightly. New $47M business wins and $25M investment signal growth, yet market reaction remains cautious. CEO transition set for 2026.
CMT stock results show that Core Molding Technologies beat analyst estimates for earnings per share and beat on revenue for the second quarter of 2024.
Given current market volatility, buying the dip in fundamentally sound stocks could be a smart move. Thus, the recent dips in Corcept Therapeutics, NextGen Healthcare, and Core Molding Technologies could represent the perfect buying opportunity.
Toward the end of trading Friday, the Dow traded up 0.62% to 34,761.24 while the NASDAQ rose 0.95% to 13,762.12. The S&P also rose, gaining 0.74% to 4,232.81.
The U.S. has the...
Companies Reporting Before The Bell
• Babcock & Wilcox (NYSE:BW) is likely to report quarterly earnings at $0.10 per share on revenue of $196.62 million.
•...
Gainers
InnSuites Hospitality Trust (NYSE: IHT) shares gained 43.4% to close at $3.50 on Friday.
Velocity Financial, Inc. (NYSE: VEL) rose 36.6% to close at $12.50 following Q1...
Midway through trading Friday, the Dow traded up 0.45% to 34,705.48 while the NASDAQ rose 1.35% to 13,816.46. The S&P also rose, gaining 0.77% to 4,233.93.
The U.S. has the...
Gainers
InnSuites Hospitality Trust (NYSE: IHT) shares jumped 77% to $4.321.
Regional Health Properties, Inc. (NYSE: RHE) gained 43% to $21.40 after dropping 23% on Thursday....
